人类血栓蛋白受体构造的调节将JAK2 V617F驱动的激活与细胞因子诱导的刺激脱离
Nicolas Papadopoulos1,2,3, Ajda Pristavec1, Audrey Nédélec1,2,3
1de Duve Institute, Université Catholique de Louvain, Brussels, Belgium.
Blood
|August 24, 2023
概括
向血栓形成素受体 (TpoR) 提供了针对骨髓增殖性瘤 (MPNs) 的新策略. 研究人员确定了特定的TpoR构造,可以选择性抑制MPN中JAK2 V617F驱动的激活.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 血栓形成素受体 (TpoR) 在骨髓增殖性瘤 (MPNs) 中至关重要.
- 像JAK2 V617F这样的突变导致异常的TpoR激活和不受控制的细胞生长.
- 目前针对JAK2激酶的治疗方法是非特异性的.
研究的目的:
- 在生理和病理状态下全面描述人类TpoR激活,特别是JAK2 V617F突变.
- 探索TpoR作为MPN的治疗目标.
- 为了确定涉及JAK2 V617F介导激活的特定TpoR形状和残留物.
主要方法:
- 利用对TpoR跨膜和细胞质域的受控二元化系统.
- 在Tpo诱导与JAK2 V617F介导信号下分析了TpoR激活构造.
- 在细胞系和原发性骨髓细胞中使用全长TpoR的证实结果.
- 研究了点突变对TpoR形状和信号的影响.
主要成果:
- 人类TpoR (hTpoR) 在Tpo诱导与JAK2 V617F激活时采用不同的二维构造.
- 确定了特定的hTpoR氨基酸和对JAK2 V617F驱动激活至关重要的二次形状.
- 证明通过点突变调节hTpoR构造可以特别抑制JAK2 V617F信号,而不会影响正常的Tpo信号.
- 在相关的细胞模型中证实了这些发现.
结论:
- 调节hTpoR构造是对JAK2 V617F阳性MPN的一种有前途的治疗策略.
- 这种方法提供了缺乏当前JAK2抑制剂疗法的特异性.
- 确定了开发MPN新型向药物的关键残留物.
相关概念视频
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


